- /
- Supported exchanges
- / US
- / DCTH.NASDAQ
Delcath Systems Inc (DCTH NASDAQ) stock market data APIs
Delcath Systems Inc Financial Data Overview
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Delcath Systems Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Delcath Systems Inc data using free add-ons & libraries
Get Delcath Systems Inc Fundamental Data
Delcath Systems Inc Fundamental data includes:
- Net Revenue: 90 441 K
- EBITDA: -1 364 500
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -0.094
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Delcath Systems Inc News
New
Delcath Systems Q1 Earnings Call Highlights
Delcath Systems logo Delcath Systems (NASDAQ:DCTH) reported first-quarter 2026 revenue growth and reiterated its full-year outlook, while updating expectations for U.S. treatment-center activations a...
Delcath Systems GAAP EPS of -$0.03 beats by $0.07, revenue of $24.99M beats by $1.58M
* Delcath Systems press release [https://seekingalpha.com/pr/20505494-delcath-systems-reports-first-quarter-2026-results-and-business-highlights] (DCTH [https://seekingalpha.com/symbol/DCTH]): Q1 GA...
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (V...
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating
We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 9, Clear Street raised its price target on Delcath Systems, Inc. (NASDAQ:DCTH) to $29 from $28 while mai...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.